Full Press Release Details
National Stock Exchange of India Ltd. (Scrip
BSE Limited (Scrip Code: 500124)
This is in reference to the Scheme
of Amalgamation and Arrangement of Dr. Reddy's Holdings Limited ("DRHL" / "Amalgamating Company")
and Dr. Reddy's Laboratories Limited ("DRL" / "Amalgamated Company") and their respective
shareholders ("Scheme"), as approved by the Hon'ble National Company Law Tribunal, Hyderabad Bench ("NCLT")
vide its Order dated April 5, 2022.
Pursuant to the Scheme, the Board
of Directors of the Company at its meeting held today, i.e. on April 22, 2022 has approved the allotment of 4,13,25,300 fully paid-up
equity shares of the face value of INR 5 each to the equity shareholders of DRHL. These equity shares will be listed on the on
the National Stock Exchange of India Ltd. and BSE Limited.
Further, 4,13,25,300 equity shares
held by DRHL i.e the Amalgamating Company in the share capital of DRL i.e. Amalgamated Company got cancelled, pursuant to the Scheme.
There is no change in promoter's
total shareholding (i.e. 26.72%) in the Company, post allotment/ cancellation of above-said equity shares.
This is for your information please
For Dr. Reddy's Laboratories
| /s/ K Randhir Singh | |
| K Randhir Singh | |
| Company Secretary & Compliance Officer |
CC: New York Stock Exchange Inc. (Stock